2017, Number 3
<< Back Next >>
Med Cutan Iber Lat Am 2017; 45 (3)
Oral PUVA therapy in a four-year-old girl with an invalidating nodular cutaneous mastocytosis
Giacaman A, Escalas TJ, Bauzá AA, Martín-Santiago A
Language: English
References: 9
Page: 237-239
PDF size: 278.86 Kb.
ABSTRACT
Mastocytosis comprises a heterogeneous group of disorders characterized by mast cell proliferation and accumulation within various organs, most commonly the skin. Treatment of cutaneous mastocytosis is aimed at reducing symptoms, avoiding agents that precipitate mediator release, use of antihistamines, glucocorticoids, sodium cromoglycate and ketotifen. Phototherapy with UVA or UVB has proven effective in controlling pruritus and cutaneous wheals, and reducing the number of mast cells in the affected skin, but to date there are few pediatric cases reported in the literature. We present a case of a four-year-old girl with a nodular cutaneous mastocytosis and systemic symptoms with minimal response to previous therapies. The patient tolerated well the treatment with PUVA, achieving an improvement in her systemic symptoms, skin lesions, and quality of life, with no immediate side effects. Although the experience reported in the literature is limited and the long-term effects are not known, we propose that PUVA could be a useful alternative in severe cases of cutaneous mastocytosis in children.
REFERENCES
Azaña JM, Torrelo A, Matito A. Update on mastocytosis (part 1): pathophysiology, clinical features, and diagnosis. Actas Dermosifiliogr. 2016; 107 (1): 5-14.
Castells M, Metcalfe DD, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol. 2011; 12 (4): 259-270.
Prignano F, Troiano M, Lotti T. Cutaneous mastocytosis: successful treatment with narrowband ultraviolet B phototherapy. Clin Exp Dermatol. 2010; 35 (8): 914-915.
Christophers E, Hönigsmann H, Wolff K, Langner A. PUVA treatment of urticaria pigmentosa. Br J Dermatol. 1978; 98 (6): 701-702.
Smith ML, Orton PW, Chu H, Weston WL. Photochemotherapy of dominant, diffuse, cutaneous mastocytosis. Pediatr Dermatol. 1990; 7 (4): 251-255.
Mackey S, Pride HB, Tyler WB. Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A. Arch Dermatol. 1996; 132 (12): 1429-1430.
Godt O, Proksch E, Streit V, Christophers E. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology. 1997; 195 (1): 35-39.
Escribano L, García-Belmonte D, Hernández-González A, Otheo E, Núñez-Lopez R, Vázquez JL et al. Successful management of a case of diffuse cutaneous mastocytosis with recurrent anaphylactoid episodes and hypertension. J Allergy Clin Immunol. 2004; 113 (2): S335.
Kinsler VA, Hawk JL, Atherton DJ. Diffuse cutaneous mastocytosis treated with psoralen photochemotherapy: case report and review of the literature. Br J Dermatol. 2005; 152 (1): 179-180.